familymednews.com
Medical or surgical treatment of severe heartburn prevents cancer of the oesophagus, a study from Karolinska Institutet with almost one million Nordic patients reveals. The results are published in the scientific journal JAMA Oncology. Pathological heartburn and acid reflux affects 10-20 per cent of the adult population. Long and severe reflux is the strongest risk factor for cancer of the […]
Continue reading »
Previous research has revealed that patients with acute myeloid leukemia who also have a particular mutation in a gene called NPM1 have a higher rate of remission with chemotherapy. About one-third of leukemia patients possess this favorable mutation, but until now, how it helps improve outcomes has remained unknown. Scientists from the University of Illinois at Chicago report on how […]
Continue reading »
(HealthDay)—Physicians can create an adherence protocol for patients, particularly children and teens, receiving treatment for atopic dermatitis, according to an article published in Dermatology Times. Lack of adherence to treatment protocols can arise for many reasons, including a lack of motivation or laziness, giving up after trying the treatment (e.g., thinking the treatment is worse or more burdensome than the […]
Continue reading »
In addition to facing new concerns about their health, individuals who are diagnosed with cancer often worry about the financial burdens of treatment. A new study indicates that many patients feel that such ‘financial toxicity’ is not adequately addressed by their doctors and other clinicians. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer […]
Continue reading »
University of Queensland researchers have discovered how to reverse drug resistance in skin and mouth squamous cell carcinomas. UQ Diamantina Institute Associate Professor Nicholas Saunders said squamous cell carcinomas was curable when diagnosed early but difficult to eradicate once the cancer spread. “This cancer of the skin and mouth kills approximately 1,400 Australians each year,” Dr. Saunders said. “The drugs […]
Continue reading »
A potentially new way of treating cerebral malaria has been discovered by scientists at the Universities of Manchester and Glasgow, in a study using mice. The authors found that inhibiting a complex called the inflammasome, at the same time as delivering anti-malarial drugs, reduced mortality from experimental cerebral malaria in mice. The research, published in PNAS and funded by the […]
Continue reading »
An international trial has found that a medicine commonly used to treat poisoning is effective in reducing deafness in children receiving chemotherapy for cancer. University of Melbourne and Royal Children’s Hospital paediatric oncologist Professor Michael Sullivan was international vice chair of the study, results of which are published in today’s New England Journal of Medicine. Professor Sullivan said the trial […]
Continue reading »
One of three epilepsy patients experience no relief from drugs and are candidates for surgery. An advance by researchers at Yale and the Cleveland Clinic will enable surgeons to more precisely target areas of the brain causing debilitating symptoms in a subset of these patients. The technology called magnetoencephalography or MEG measures small amounts of magnetic-electrical activity on the surface […]
Continue reading »
The results of a 23-year, follow-up study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest early, intensive treatment of rheumatoid arthritis has long-term benefits including the normalisation of mortality to levels consistent with the general population. “We know that the adverse effects of rheumatoid arthritis on the body only become truly apparent after more than a […]
Continue reading »
An experimental drug has shown promise as a potential therapy for spinal cord injuries in animal studies. The compound, 4-aminopyridine-3-methanol, works in a similar way as a drug previously developed at Purdue, 4-aminopyridine (4-AP), which has been approved by the U.S. Food and Drug Administration to treat multiple sclerosis. Dr. Riyi Shi, professor in the Department of Basic Medical Sciences, […]
Continue reading »